Skip to main content

Diabetes

  • Navarro Discount Pharmacy celebrates opening of 30th store

    MIAMI — Navarro Discount Pharmacy, a Hispanic-owned pharmacy chain and an MBF Healthcare portfolio company, has opened its 30th store in Homestead in the Homestead Pavilion Shopping Center.

  • FDA issues draft guidance to investigators, manufacturers of artificial pancreas systems

    SILVER SPRING, Md. — In an effort to help advance the development of devices that automatically monitor blood glucose and provide proper insulin doses in people with Type 1 diabetes, the Food and Drug Administration has issued draft guidance to help investigators and manufacturers as they develop and seek approval for these products.

  • Meta-analysis: Liquid cinnamon extract helps control blood-sugar levels

    TUSTIN, Calif. — A new meta-analysis released Wednesday of eight clinical trials examining the effect of cinnamon consumption in people with Type 2 diabetes and/or prediabetes concluded cinnamon extract and/or cinnamon helps lower blood-glucose levels. The analysis was published in the Journal of Medicinal Foods.

  • Study: Elevated glucose levels may be linked to colorectal cancer

    BRONX, N.Y. — A new study conducted by researchers at Yeshiva University's Albert Einstein College of Medicine found that high blood-sugar levels may be associated with an increased risk of colorectal cancer.

    Researchers examined the fasting blood sugar and insulin levels of nearly 5,000 postmenopausal women — all of whom were enrolled in the National Institutes of Health's landmark Women's Health Initiative study — several times over a 12-year period.

  • Lilly study to determine why many diabetes patients don't reach blood-glucose goals

    INDIANAPOLIS — Many people with Type 2 diabetes have managed to integrate the treatments they must take into their daily lives, but many do not reach their blood-glucose goals after they start insulin therapy.

    Drug maker Eli Lilly is partnering with Brigham and Women's Hospital in Boston in a study that started in July and has enrolled 4,500 people in 17 countries to find out why many people with the disease resist a progression of insulin therapy.

  • DSN Industry Issues Summit breaks attendance records

    NEW YORK — Record-breaking attendance, a high-profile keynote speaker, four engaging panel discussions on some of the hottest issues facing the industry and exclusive consumer videos set the stage for the 13th annual Drug Store News Industry Issues Summit held on Tuesday in New York.

  • CDC: Elderly patients at risk of emergency hospitalizations from blood thinners, diabetes medications

    ATLANTA — Many elderly patients put themselves at risk for emergency hospitalization due to adverse drug events, according to a new Centers for Disease Control and Prevention study published in the New England Journal of Medicine.

  • Study: Metformin may reduce risk of cancer

    EAST LANSING, Mich. — A drug commonly used to treat Type 2 diabetes may reduce the risk of diabetes-associated cancers, including breast cancer, according to a new study.

X
This ad will auto-close in 10 seconds